My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pfizer (NY:PFE)

25.85 +0.05 (+0.19%)

Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

2 Large-Cap Stocks with Exciting Potential and 1 We Avoid

October 21, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche ↗

October 20, 2025

The company took on Roche's Xolair in a 16-week study of patients with a chronic hives disorder.

Via Investor's Business Daily

Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy

October 20, 2025

From Arvinas Inc.

Via GlobeNewswire

Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payout ↗

October 14, 2025

Via Stocktwits

Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts

October 19, 2025

The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened...

Via MarketMinute

2 High-Yield Dividend Stocks Too Cheap to Ignore ↗

October 19, 2025

They are both yielding above 5%.

Via The Motley Fool

Topics Intellectual Property World Trade

Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer

October 19, 2025

From Pfizer Inc.

Via Business Wire

XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer

October 19, 2025

From Pfizer Inc.

Via Business Wire

Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients ↗

October 18, 2025

Pharma titans Merck, Pfizer and Astellas Pharma are delivering an "enormous new hope" for patients with bladder cancer.

Via Investor's Business Daily

Invo Fertility Stock Is Plunging After White House Announcement ↗

October 17, 2025

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.

Via Benzinga

Why Eli Lilly (LLY) Stock Is Down Today

October 17, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s...

Via StockStory

Topics Economy Government

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment ↗

October 17, 2025

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to daily oral medication.

Via Benzinga

QSM Asset Management Dumps 36,000 Whirlpool (WHR) Shares in Q3 2025 ↗

October 17, 2025

Via The Motley Fool

Topics Regulatory Compliance

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? ↗

October 17, 2025

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential impact on Eli Lilly and Pfizer.

Via Benzinga

Topics Government

Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug ↗

October 17, 2025

Eli Lilly said Friday a combo using Verzenio cut the risk of death by nearly 16% over two years for breast cancer patients.

Via Investor's Business Daily

ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million ↗

October 16, 2025

Via The Motley Fool

Topics Regulatory Compliance

AI: The Medical Maverick – Navigating Hype and Hope in Healthcare’s Digital Revolution

October 16, 2025

Artificial intelligence (AI) stands at the precipice of a profound transformation in healthcare, promising a future where diagnostics are sharper, treatments are more personalized, and patient care is...

Via TokenRing AI

Topics Artificial Intelligence

QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure ↗

October 16, 2025

Via The Motley Fool

Navigating the Currents: Volatility and Growth Define U.S. Markets Amidst AI Boom and Geopolitical Headwinds

October 16, 2025

As of October 16, 2025, the U.S. stock market is a tapestry woven with threads of robust corporate earnings, groundbreaking technological advancements, and persistent geopolitical and economic...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market ↗

October 16, 2025

Via The Motley Fool

A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years ↗

October 16, 2025

It's the best time in a while to scoop up shares of this stock from the discount bin.

Via The Motley Fool

Topics Intellectual Property World Trade

Why Moderna Might Be a One-Hit Wonder ↗

October 15, 2025

Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines.

Via The Motley Fool

Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025

October 15, 2025

In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Curious about the most active S&P500 stocks in today's session? ↗

October 15, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Wall Street's Earnings Momentum Fades, Market Dips Amidst Trade Tensions

October 15, 2025

Wall Street witnessed a significant shift this Wednesday as an eagerly anticipated earnings push ultimately petered out, sending stocks into the red. This downturn followed a volatile Tuesday, which...

Via MarketMinute

Topics Economy Supply Chain World Trade

Pfizer CEO Reportedly Says Vaccine Approvals Getting Harder ↗

October 15, 2025

According to a report from Bloomberg, Bourla said that it's harder to get vaccine approvals and not drug approvals.

Via Stocktwits

Topics Government World Trade

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields ↗

October 15, 2025

Via Benzinga

1 Safe-and-Steady Stock Worth Your Attention and 2 We Question

October 15, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

AI Revolutionizes Quality Control: A New Era of Precision and Speed in Manufacturing, Electronics, and Pharmaceuticals

October 14, 2025

A groundbreaking wave of Artificial Intelligence (AI) tools is poised to fundamentally transform materials quality checking, ushering in an era of unparalleled precision, speed, and cost-efficiency...

Via MarketMinute

Topics Artificial Intelligence Economy Fraud

Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech

October 14, 2025

The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations...

Via MarketMinute

Topics Economy Government Regulatory Compliance

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.